Gynazol (Butoconazole Nitrate)

Gynazol is indicated for the treatment of vaginal candidiasis caused by susceptible Candida species.

• Management of acute vulvovaginal yeast infections.
• Adjunct therapy for recurrent Candida infections when prescribed by a clinician.
• Treatment of symptomatic vaginal itching, burning, and discharge associated with candidiasis.
• Use in adult women following confirmed diagnosis of fungal vaginitis.
• Therapeutic option for patients who cannot tolerate oral antifungal agents.
• Consideration for use in women preferring topical over systemic therapy.

Possible adverse reactions to Gynazol are generally mild, but serious events have been reported rarely.

Common

• Local irritation or burning at the application site.
• Vaginal itching or mild discomfort.
• Increased vaginal discharge with a watery or milky appearance.
• Mild abdominal cramping.

Serious

• Allergic reaction presenting as rash, swelling, or hives.
• Severe vaginal inflammation or ulceration.
• Signs of systemic hypersensitivity such as difficulty breathing.

Before using Gynazol, certain precautions should be considered to ensure safe and effective treatment.

• Confirm diagnosis of vaginal candidiasis before initiating therapy.
• Avoid use if you have a known hypersensitivity to butoconazole nitrate or other imidazole antifungals.
• Do not use during active vaginal infections of bacterial or parasitic origin without medical advice.
• Pregnancy and breastfeeding status should be discussed with a healthcare provider.
• If symptoms persist beyond the recommended treatment period, seek further medical evaluation.
• Do not insert the applicator beyond the recommended depth to prevent mucosal injury.

Gynazol may interact with other medications or substances applied vaginally; awareness of these interactions helps minimize risk.

Avoid

• Concurrent use of other vaginal antifungal or antiseptic products without professional guidance.
• Co‑administration with intravaginal estrogen creams that may alter local absorption.

Use with caution

• Systemic azole antifungals (e.g., fluconazole) as they may increase overall azole exposure.
• Topical corticosteroids applied to the vaginal area, which could mask irritation.
• Chemotherapeutic agents that suppress immune function, potentially affecting treatment response.